Market Overview

United Therapeutics Gets Favorable Ruling, Shares Flying Higher


Shares of United Therapeutics (NASDAQ: UTHR) are trading sharply higher on news that patent infringement ruling against competitor Sandoz.

The ruling disallows Sandoz to sell the generic version of United Therapeutics hypertension drug Remodulin before 2017.

Shares were trading up more than 24 percent to $114.47.

Posted-In: News Legal Movers


Related Articles (UTHR)

View Comments and Join the Discussion!

Gas Prices May Continue To Fall For Labor Day Weekend And Beyond

Benchmark Talks Of Activision Bid For Take-Two Sends Shares Higher